These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16902932)

  • 1. GR ligands: can we improve the established drugs?
    Rehwinkel H; Schäcke H
    ChemMedChem; 2006 Aug; 1(8):803-5. PubMed ID: 16902932
    [No Abstract]   [Full Text] [Related]  

  • 2. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the glucocorticoid receptor and producing therapeutic agents with anti-inflammatory effects but reduced side-effects.
    McMaster A; Ray DW
    Exp Physiol; 2007 Mar; 92(2):299-309. PubMed ID: 17138619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of new nonsteroidal glucocorticoid modulators through application of an "agreement docking" method.
    Barker M; Clackers M; Demaine DA; Humphreys D; Johnston MJ; Jones HT; Pacquet F; Pritchard JM; Salter M; Shanahan SE; Skone PA; Vinader VM; Uings I; McLay IM; Macdonald SJ
    J Med Chem; 2005 Jul; 48(14):4507-10. PubMed ID: 15999989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands.
    Shah N; Scanlan TS
    Bioorg Med Chem Lett; 2004 Oct; 14(20):5199-203. PubMed ID: 15380227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A plant-derived glucocorticoid receptor modulator attenuates inflammation without provoking ligand-induced resistance.
    Gossye V; Elewaut D; Van Beneden K; Dewint P; Haegeman G; De Bosscher K
    Ann Rheum Dis; 2010 Jan; 69(1):291-6. PubMed ID: 19204014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery and optimization of novel, non-steroidal glucocorticoid receptor modulators.
    Ray NC; Clark RD; Clark DE; Williams K; Hickin HG; Crackett PH; Dyke HJ; Lockey PM; Wong M; Devos R; White A; Belanoff JK
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4901-5. PubMed ID: 17587578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analgesic therapy for dental pain: the nonsteroidal anti-inflammatory drugs.
    Rye LA; Terezhalmy GT
    J Oral Med; 1985; 40(1):51-3. PubMed ID: 3871851
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure-based design of a new class of anti-inflammatory drugs: secretory phospholipase A(2) inhibitors, SPI.
    Mihelich ED; Schevitz RW
    Biochim Biophys Acta; 1999 Nov; 1441(2-3):223-8. PubMed ID: 10570250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-steroidal steroid receptor modulators.
    Hermkens PH; Kamp S; Lusher S; Veeneman GH
    IDrugs; 2006 Jul; 9(7):488-94. PubMed ID: 16821162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation.
    Moussaieff A; Shohami E; Kashman Y; Fride E; Schmitz ML; Renner F; Fiebich BL; Munoz E; Ben-Neriah Y; Mechoulam R
    Mol Pharmacol; 2007 Dec; 72(6):1657-64. PubMed ID: 17895408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanism of glucocorticoid action].
    Tanaka H
    Ryumachi; 2002 Feb; 42(1):13-22. PubMed ID: 11925903
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent developments in the discovery of selective glucocorticoid receptor modulators (SGRMs).
    Hudson AR; Roach SL; Higuchi RI
    Curr Top Med Chem; 2008; 8(9):750-65. PubMed ID: 18537686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separating transrepression and transactivation: a distressing divorce for the glucocorticoid receptor?
    Newton R; Holden NS
    Mol Pharmacol; 2007 Oct; 72(4):799-809. PubMed ID: 17622575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutic agents targeting the glucocorticoid receptor for inflammation and cancer.
    Sommer P; Ray DW
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1070-7. PubMed ID: 18821468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug insight: selective agonists and antagonists of the glucocorticoid receptor.
    McMaster A; Ray DW
    Nat Clin Pract Endocrinol Metab; 2008 Feb; 4(2):91-101. PubMed ID: 18212811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fragment based design of new H4 receptor-ligands with anti-inflammatory properties in vivo.
    Smits RA; Lim HD; Hanzer A; Zuiderveld OP; Guaita E; Adami M; Coruzzi G; Leurs R; de Esch IJ
    J Med Chem; 2008 Apr; 51(8):2457-67. PubMed ID: 18357976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSAIDs revisited: putative molecular basis of their interactions with peroxisome proliferator-activated gamma receptor (PPARgamma).
    Romeiro NC; Sant'Anna CM; Lima LM; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2008 Sep; 43(9):1918-25. PubMed ID: 18222570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamines in inflammation and their modulation by conventional anti-inflammatory drugs.
    Chakradhar LV; Naik SR
    Indian J Exp Biol; 2007 Jul; 45(7):649-53. PubMed ID: 17821863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desirability-based multiobjective optimization for global QSAR studies: application to the design of novel NSAIDs with improved analgesic, antiinflammatory, and ulcerogenic profiles.
    Cruz-Monteagudo M; Borges F; Cordeiro MN
    J Comput Chem; 2008 Nov; 29(14):2445-59. PubMed ID: 18452123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.